Inhalation Anesthetics Market, By Product (Desflurane, Sevoflurane, Isoflurane, and Other Products), By End User (Hospitals and Ambulatory Surgical Centers), By Application (Induction and Maintenance), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI398220 | Publish Date: June 2023 | No. of Pages: 155

Global Inhalation Anesthetics Market By Overview

Introduction:

Inhalation Anesthetics help to avoid excessive dosage and keeps the patient’s autonomic functions intact. These drugs are eradicated through lungs and they have minor chances of accumulation in the body. The most common inhalational anesthetics are desflurane, sevoflurane, and nitrous oxide. Among these, sevoflurane is the most common due to its rapid onset of action and the point that patients recover quickly from it. Inhalational anesthetics lead to respiratory depression, reduction in arterial blood pressure and cerebral metabolic demand, and growth in cerebral blood flow.

Drivers and Restraints:

A growing number of surgical procedures requiring anesthesia, rising usage of inhalable anesthetics, and technological advancements about anesthesia delivery devices in the emerging markets, such as China and India are the major factors driving the growth of the target market. According to the Centers of Disease Control and Prevention (CDC) in 2017, more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the U.S. Increasing number of surgeries in Asia-Pacific (especially in China and India), mainly because of the high patient population levels is also boosting growth of the global market. Moreover, technological advancements in the anesthesia techniques and machines are also propelling the adoption rate of inhalation anesthetics. For instance, Sedana Medical advanced an anesthetic delivery system, AnaConDa, which allows the efficient and safe delivery of volatile anesthetics, such as sevoflurane or isoflurane, to the invasively ventilated patients. However, the launch of generic counterparts of inhalation anesthetics is one of the major hampering factors for the growth of the global market. Introduction of generics leads to a sharp decline in the usage of patented products. Furthermore, generic drugs also lead to pricing pressure on branded counterparts, which in turn, restricts the global market growth, in terms of revenue.

Segmentation:

The global inhalation anesthetics market is segmented based on the product, end-user, application, and region.

Based on the product, the global inhalation anesthetics market is segmented into desflurane, sevoflurane, isoflurane, and other products. Based on end-user, the target market is classified into hospitals and ambulatory surgical centres. Based on the application, the target market is classified into induction and maintenance.

On the region, the global inhalation anesthetics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2018, North America led the target market and is projected to grow at a profitable rate during the forecast period, due to the growing prevalence of various chronic diseases and availability of advanced healthcare facilities. Also, the demand for surgical products which includes ambulatory surgery and inpatient surgery is the highest in North America and is a major growth booster for the regional market. Furthermore, Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period. Key factors contributing to its rapid growth include public and private healthcare expenditure, rising population, the incidence of chronic diseases, and availability of healthcare insurance for masses. Moreover, growth in medical tourism along with rapid penetration of insurance coverage will permit more people to opt for surgical products and is projected to lucratively drive the usage of inhalation anesthetics.

Key Players:   

The key players operating the global inhalation anesthetics market include AbbVie Inc., Novartis AG (Sandoz), Fresenius SE & Co. KGaA, Baxter International Inc., Halocarbon Products Corporation, Lunan Pharmaceuticals Group, Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co. Ltd., Piramal Group, and Troikaa Pharmaceuticals Ltd. Prominent players operating in the target market are focusing on the strategic partnerships as well as the launching of the products to gain competitive edge in the target market. For instance, in July 2019, Hikma Pharmaceuticals PLC and Gedeon Richter PLC declared the signing of an exclusive license agreement to commercialize cariprazine, a novel antipsychotic, in certain Middle East and North African (MENA) markets.

Detailed Segmentation:

Global Inhalation Anesthetics Market, By Product:

  • Desflurane
  • Sevoflurane
  • Isoflurane
  • Other Products

Global Inhalation Anesthetics Market, By End-user:

  • Hospitals
  • Ambulatory Surgical Centers

Global Inhalation Anesthetics Market, By Application:

  • Induction
  • Maintenance

Global Inhalation Anesthetics Market, By Region:

      • North America
        • North America Inhalation Anesthetics Market, By Product
        • North America Inhalation Anesthetics Market, By End-user
        • North America Inhalation Anesthetics Market, By Application
        • North America Inhalation Anesthetics Market, By Country
          • U.S.
          • Canada
      • Europe
        • Europe Inhalation Anesthetics Market, By Product
        • Europe Inhalation Anesthetics Market, By End-user
        • Europe Inhalation Anesthetics Market, By Application
        • Europe Inhalation Anesthetics Market, By Country
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
        • Asia Pacific Inhalation Anesthetics Market, By Product
        • Asia Pacific Inhalation Anesthetics Market, By End-user
        • Asia Pacific Inhalation Anesthetics Market, By Application
        • Asia Pacific Inhalation Anesthetics Market, By Country
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
        • Latin America Inhalation Anesthetics Market, By Product
        • Latin America Inhalation Anesthetics Market, By End-user
        • Latin America Inhalation Anesthetics Market, By Application
        • Latin America Inhalation Anesthetics Market, By Country
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
        • Middle East & Africa Inhalation Anesthetics Market, By Product
        • Middle East & Africa Inhalation Anesthetics Market, By End-user
        • Middle East & Africa Inhalation Anesthetics Market, By Application
        • Middle East & Africa Inhalation Anesthetics Market, By Country
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Company Profile:

        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Business Strategies
  • Novartis AG (Sandoz)
  • Fresenius SE & Co. KGaA
  • Baxter International Inc.
  • Halocarbon Products Corporation
  • Lunan Pharmaceuticals Group
  • Hikma Pharmaceuticals PLC
  • Jiangsu Hengrui Medicine Co. Ltd.
  • Piramal Group
  • Troikaa Pharmaceuticals Ltd.

 “*” marked represents similar segmentation in other categories in the respective section

Global Inhalation Anesthetics Market By Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Inhalation Anesthetics Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product
      • Market Snippet, By End-user
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Inhalation Anesthetics Market, By Product, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Desflurane
      • Overview
      • Market Inhalation Anesthetics and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Sevoflurane
      • Overview
      • Market Inhalation Anesthetics and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Isoflurane
      • Overview
      • Market Inhalation Anesthetics and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Products
      • Overview
      • Market Inhalation Anesthetics and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Inhalation Anesthetics Market, By End-user, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospital
      • Overview
      • Market Inhalation Anesthetics and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Ambulatory Surgical Centers
      • Overview
      • Market Inhalation Anesthetics and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Inhalation Anesthetics Market, By Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Induction
      • Overview
      • Market Inhalation Anesthetics and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Maintenance
      • Overview
      • Market Inhalation Anesthetics and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Inhalation Anesthetics Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Product, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By End-user, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Inhalation Anesthetics and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  10. Company Profiles
      • AbbVie, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • Novartis AG (Sandoz)
      • Fresenius SE & Co. KGaA
      • Baxter International Inc.
      • Halocarbon Products Corporation
      • Lunan Pharmaceuticals Group
      • Hikma Pharmaceuticals PLC
      • Jiangsu Hengrui Medicine Co. Ltd.
      • Piramal Group
      • Troikaa Pharmaceuticals Ltd.
  11. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The Inhalation Anesthetics Market report segments the market been segmented on the based on the Product, End User, Application and region.

The growing factors related to the Inhalation Anesthetics Market growth include the increasing prevalence of chronic diseases, growing number of surgeries, and advancements in inhalation anesthesia delivery technology.

North America is dominating the global Inhalation Anesthetics market as compared to that of other regions.

The leading players operating in the Inhalation Anesthetics Market includes AbbVie Inc., Novartis AG (Sandoz), Fresenius SE & Co. KGaA, Baxter International Inc., Halocarbon Products Corporation, Lunan Pharmaceuticals Group, Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co. Ltd., Piramal Group, and Troikaa Pharmaceuticals Ltd.